• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道葡萄糖排泄:血糖控制的潜在机制。

Intestinal glucose excretion: A potential mechanism for glycemic control.

机构信息

Department of General Surgery, Daping Hospital, Army Medical University, Chongqing 400042, China.

Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Army Medical University, Chongqing Institute of Hypertension, Chongqing 400042, China.

出版信息

Metabolism. 2024 Mar;152:155743. doi: 10.1016/j.metabol.2023.155743. Epub 2023 Nov 24.

DOI:10.1016/j.metabol.2023.155743
PMID:38007149
Abstract

The gut has been increasingly recognized in recent years as a pivotal organ in the maintenance of glucose homeostasis. Specifically, the profound and enduring improvement in glucose metabolism achieved through metabolic surgery to modify the anatomy of the gut has prompted scholars to acknowledge that the most effective strategy for treating type 2 diabetes mellitus (T2DM) involves the gut. The mechanisms underlying the regulation of glucose metabolism by the gut encompass gut hormones, bile acids, intestinal gluconeogenesis, gut microbiota, and signaling interactions between the gut and other organs (liver, brain, adipose, etc.). Recent studies have also revealed a novel phenomenon of glucose lowering through the gut: metabolic surgery and metformin promote the excretion of glucose from the circulation into the intestinal lumen by enterocytes. However, there is still limited understanding regarding the underlying mechanisms of intestinal glucose excretion and its contribution to glycemic control. This article reviews current research on intestinal glucose excretion while focusing on its role in T2DM management as well as potential mechanisms.

摘要

近年来,人们越来越认识到肠道是维持葡萄糖内稳态的关键器官。具体来说,通过代谢手术改变肠道解剖结构来改善葡萄糖代谢的深远而持久的效果,促使学者们承认治疗 2 型糖尿病(T2DM)最有效的策略涉及肠道。肠道调节葡萄糖代谢的机制包括肠道激素、胆汁酸、肠内葡萄糖生成、肠道微生物群以及肠道与其他器官(肝脏、大脑、脂肪等)之间的信号相互作用。最近的研究还揭示了通过肠道降低血糖的一种新现象:代谢手术和二甲双胍通过肠细胞促进葡萄糖从循环中排出到肠腔中。然而,对于肠道葡萄糖排泄的潜在机制及其对血糖控制的贡献,仍知之甚少。本文综述了目前关于肠道葡萄糖排泄的研究,重点介绍了其在 T2DM 管理中的作用以及潜在的机制。

相似文献

1
Intestinal glucose excretion: A potential mechanism for glycemic control.肠道葡萄糖排泄:血糖控制的潜在机制。
Metabolism. 2024 Mar;152:155743. doi: 10.1016/j.metabol.2023.155743. Epub 2023 Nov 24.
2
Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.饮食诱导肥胖中,胃旁路手术微生物群的功能变化通过肠道 FXR-TGR5 串扰重新激活产热脂肪组织和全身葡萄糖控制。
Microbiome. 2022 Jun 24;10(1):96. doi: 10.1186/s40168-022-01264-5.
3
Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.Roux-en-Y 胃旁路手术通过增加血清胆汁酸水平和肝法尼醇 X 受体表达改善 2 型糖尿病大鼠模型的代谢状况。
Obes Surg. 2019 Sep;29(9):2912-2922. doi: 10.1007/s11695-019-03918-0.
4
Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model.Roux-en-Y胃旁路手术在2型糖尿病大鼠模型中抑制肝糖异生并增加肠糖异生。
Obes Surg. 2016 Nov;26(11):2683-2690. doi: 10.1007/s11695-016-2157-5.
5
Serum glucose excretion after Roux-en-Y gastric bypass: a potential target for diabetes treatment.胃旁路术后的血清葡萄糖排泄:糖尿病治疗的一个潜在靶点。
Gut. 2021 Oct;70(10):1847-1856. doi: 10.1136/gutjnl-2020-321402. Epub 2020 Nov 18.
6
EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.EndoBarrier胃肠道内衬。潜在机制及临床效果的描述。
Dan Med J. 2016 Nov;63(11).
7
The effects of laparoscopic Roux-en-Y gastric bypass and one-anastomosis gastric bypass on glycemic control and remission of type 2 diabetes mellitus: study protocol for a multi-center randomized controlled trial (the DIABAR-trial).腹腔镜 Roux-en-Y 胃旁路手术和单吻合口胃旁路手术对 2 型糖尿病血糖控制和缓解的影响:多中心随机对照试验(DIABAR 试验)研究方案。
Trials. 2022 Oct 22;23(1):900. doi: 10.1186/s13063-022-06762-3.
8
Gut Microbiota Contribution to Weight-Independent Glycemic Improvements after Gastric Bypass Surgery.胃旁路手术后肠道微生物组对血糖改善的非体重依赖性作用。
Microbiol Spectr. 2023 Jun 15;11(3):e0510922. doi: 10.1128/spectrum.05109-22. Epub 2023 Apr 6.
9
Portal milieu and the interplay of multiple antidiabetic effects after gastric bypass surgery.胃旁路手术后的门脉环境和多种抗糖尿病作用的相互作用。
Am J Physiol Gastrointest Liver Physiol. 2019 May 1;316(5):G668-G678. doi: 10.1152/ajpgi.00389.2018. Epub 2019 Mar 21.
10
A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.与抗糖尿病作用相关的特定肠道微生物群和代谢组学特征变化:食用美人蕉3型抗性淀粉与二甲双胍相似且互补的抗糖尿病特性。
Pharmacol Res. 2020 Sep;159:104985. doi: 10.1016/j.phrs.2020.104985. Epub 2020 Jun 3.

引用本文的文献

1
Navigating contradictions in enteric chemotactic stimuli.应对肠道趋化性刺激中的矛盾之处。
Elife. 2025 Aug 11;14:RP106261. doi: 10.7554/eLife.106261.
2
Novel mechanism whereby metformin improves glucose homeostasis: TXNIP-GLUT1 axis modulation enhances intestinal glucotonic effects.二甲双胍改善葡萄糖稳态的新机制:TXNIP-GLUT1轴调节增强肠道葡萄糖生成作用。
Exp Mol Med. 2025 Aug 6. doi: 10.1038/s12276-025-01518-w.
3
Gut microbiota alterations induced by Roux-en-Y gastric bypass result in glucose-lowering by enhancing intestinal glucose excretion.
Roux-en-Y胃旁路手术引起的肠道微生物群改变通过增强肠道葡萄糖排泄降低血糖。
Gut Microbes. 2025 Dec;17(1):2473519. doi: 10.1080/19490976.2025.2473519. Epub 2025 Mar 3.
4
Understanding the action mechanisms of metformin in the gastrointestinal tract.了解二甲双胍在胃肠道中的作用机制。
Front Pharmacol. 2024 Mar 28;15:1347047. doi: 10.3389/fphar.2024.1347047. eCollection 2024.
5
Navigating contradictions: Typhimurium chemotactic responses to conflicting effector stimuli.应对矛盾:鼠伤寒沙门氏菌对相互冲突的效应刺激的趋化反应
bioRxiv. 2025 Feb 10:2024.01.18.576330. doi: 10.1101/2024.01.18.576330.